In our study, 500-1000 mL tap water was administered as an oral contrast medium to each patient immediately before CT to distend the stomach. Each patient had fasted for > 6 hours, and had received a 2 mL/kg intravenous dose (total volume, < 150 mL; 3 mL/sec) of nonionic contrast material (Ultravist 300; Schering, Berlin, Germany) through an 18-G angiographic catheter inserted in a forearm vein using an automatic power injector (Stellant D; Medrad, Pittsburgh, PA, USA). After obtaining unenhanced CT images, portal venous phase images were acquired 60-70 seconds after administration of the contrast medium.
S-CT scans were obtained in the prone position, and the scanning field ranged from the diaphragmatic dome to the anal verge. All examinations were performed during deep inspiration.
Axial S-CT images were reconstructed with 5 mm section thickness and a 5 mm reconstruction interval for clinical interpretation, in addition to axial images. Coronal multiplanar reconstruction (MPR) images were reconstructed with a 3 mm section thickness at a 3 mm interval.
F-FDG PET/CT Protocol
All patients were instructed to fast for 8 hours (except for glu- 
MATERIALS AND METHODS

Patients
This retrospective study was approved by our Institutional Review Board, and informed consent was waived. A total of 329 patients were pathologically confirmed with gastric cancer in The stomach was divided into three segments along the longitudinal axis (from the gastroesophageal junction to the pyloric canal) of upper, middle, and lower thirds (8) . If the gastric cancer was located across segments, the position of the gastric cancer was set where the lesion had the greatest involvement. Fig. 1 ).
In the consensus reading, sensitivities for detecting all primary using MedCalc Software, v.12.7.8 statistical software (Mariakerke, Belgium), SAS 9.2 (SAS Institute, Cary, NC, USA), or SPSS 19.0 software (SPSS Inc., Chicago, IL, USA). A p-value < 0.05 was considered significant.
RESULTS
Of the 267 primary gastric cancers, 22 lesions were located in Table 1 Table 2 ).
Six false-positive lesions were noted by both readers in the S-CT set during the consensus reading. All six lesions showed mild mucosal enhancement or subtle elevated lesions on portal phase S-CT scans. These lesions were not detected on the 18 F-FDG PET/CT set. Endoscopic or pathological findings of these lesions suggested gastritis or non-specific lesions. However, these lesions were regarded as negative lesions on the combined set.
Interobserver agreement for detecting all lesions, EGCs, and AGCs was excellent (k = 0.764-0.914) ( Table 3) .
DISCUSSION
Gastric cancer is one of the most common malignant tumors of the alimentary tract. Improved early diagnosis, accurate clinigastric cancers and EGCs were significantly higher with the combined set (66.3% for all lesions; 50.8% for EGCs) than those with the S-CT set (61.4% for all lesions; 40.2% for EGCs) and with the 18 F-FDG PET/CT set (42.3% for all lesions; 27.9% for EGCs) (Fig. 2) . The combined set also had significantly higher sensitivity (98.9%) than that of the 18 F-FDG PET/CT set (72.7%), but no significant difference was observed with the S-CT set (97.7%) for detecting AGCs (Fig. 3 tion and staging patients with gastric cancer. However, its use for detecting gastric cancer is limited because CT has a primary tumor detection rate of 85-95% in patients with AGC (1, 11, 12) cal staging, and optimal surgical procedures are essential to improve prognosis (10) .
CT has been the modality of choice for the preoperative evalua- This study had some limitations. First, this study was a retrospective, single institution study over a defined period. Second, we did not include CT gastrography, which is helpful for detecting primary gastric cancer (3). Therefore, a further comparative study is needed using S-CT and CT gastrography to detect primary gastric cancer. Third, this study was conducted in a highly selected patient population with primary gastric cancer diagnosed by endoscopic biopsy. Thus, it was unclear to what degree the current findings can be generalized to a wider population. EGC. Studies in which dynamic or multiphase scanning was used to evaluate EGC achieved detection rates of 44-93.5% (1, 3, (13) (14) (15) (16) ). In our study, sensitivities of 40.2% and 97.7% were observed in patients with EGC and AGC, respectively, using S-CT alone.
S-CT alone was limited to detect lesions in patients with EGC. 18 F-FDG PET has no role in primary gastric cancer detection due to its low sensitivity, particularly in EGC (17) . Our study also showed sensitivity of 27.9% in patients with EGC using 
